Spain Ophthalmic Devices - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2026-2031)

The spain ophthalmic devices market size is projected to expand from USD 1.24 billion in 2025 and USD 1.31 billion in 2026 to USD 1.73 billion by 2031, registering a CAGR of 5.67% between 2026 to 2031. This report is Segmented by Device Type (Diagnostic & Monitoring Devices, Surgical Devices, and Vision Care Devices), Disease Indication (Cataract, Glaucoma, Diabetic Retinopathy, Other Disease Indications), End-User (Hospitals, Specialty Ophthalmic Clinics, and More). The Market Forecasts are Provided in Terms of Value (USD).

Spain Ophthalmic Devices Market Trends and Insights

Rapidly Ageing Population Driving Cataract, AMD & Glaucoma Procedures

Life expectancy reached 83.2 years in 2024, and the share of citizens aged 65 or above rose to 20.4% in 2025, trends projected to accelerate through 2050. Cataract prevalence now exceeds 60% among Spaniards older than 70, generating roughly 450,000 surgeries each year. Regions with the oldest populations are refreshing their phaco systems and premium intraocular-lens inventories to meet demand. Universal insurance coverage stabilizes procedure volumes, yet rural dispersion steers interest to portable OCT scanners and smartphone fundus cameras for primary-care triage.

AI-Enabled OCT & Fundus Imaging Adoption Across Spanish Hospitals

Navarre’s NaIA-RD platform screened 78,000 diabetic patients in 2024 with 94% sensitivity, and Catalonia’s MIRA network processed more than 100,000 images in the same year. These pilots relieve specialist bottlenecks, important because Spain has one ophthalmologist for every 4,200 residents. Vendors now embed AI into device firmware; Heidelberg Engineering’s SPECTRALIS update trims image-interpretation time to two minutes. Regulatory backing is solid, with 12 CE marks for ophthalmic AI software granted in 2024.

High Capital Cost & Restricted Reimbursement for Premium Devices

Femtosecond lasers cost between EUR 400,000 and EUR 600,000, yet public reimbursement per cataract case is EUR 1,850, unchanged since 2019. Private insurers cover upgrades only in high-tier plans, limiting access to 18% of privately insured citizens. Hospitals, therefore, favor durable, high-throughput systems over premium platforms, bifurcating the Spanish ophthalmic devices market into cost-focused public tenders and technology-driven private clinics.

Other drivers and restraints analyzed in the detailed report include:

• Government Recovery-Plan Funding for Ophthalmic Equipment
• Expansion of Private Ophthalmology Chains Boosting Device Procurement
• Stringent EU MDR / AEMPS Approval Timelines

Segment Analysis

Vision Care Devices held 60.59% of Spain ophthalmic devices market share in 2025, anchored by 1,200 optical stores run by EssilorLuxottica’s GrandVision and Multiópticas, while CooperVision lenses secured about 28% of contact-lens revenue. Diagnostic & Monitoring Devices will post a 7.64% CAGR to 2031, the fastest among categories, because hospitals invest in swept-source OCT and AI-ready fundus cameras. OCT scanners alone account for 37% of diagnostic revenue, and Carl Zeiss Meditec and Heidelberg Engineering units are present in roughly 65% of public hospitals.

Spain ophthalmic devices market size for surgical platforms is rising as femtosecond lasers replace manual capsulotomy, and micro-invasive glaucoma implants see wider pairing with cataract procedures. Vitreoretinal tools are shifting to 27-gauge instrumentation for faster recovery, and robotic prototypes are slated for commercial launch after 2026.

Complete Report Scope:

• By Device Type
  • Diagnostic & Monitoring Devices
    • OCT Scanners
    • Fundus & Retinal Cameras
    • Corneal Topography Systems
    • Ultrasound Imaging Systems
    • Other Diagnostic & Monitoring Devices
  • Surgical Devices
    • Cataract Surgical Devices
    • Vitreoretinal Surgical Devices
    • Glaucoma Surgical Devices
    • Other Surgical Devices
  • Vision Care Devices
    • Spectacles Frames & Lenses
    • Contact Lenses
• By Disease Indication
  • Cataract
  • Glaucoma
  • Diabetic Retinopathy
  • Other Disease Indications
• By End-user
  • Hospitals
  • Specialty Ophthalmic Clinics
  • Ambulatory Surgery Centers (ASCs)
  • Other End-users

List of Companies Covered in this Report:

• Alcon
• Bausch + Lomb
• BVI Medical
• Carl Zeiss
• Clínica Baviera
• The Cooper Companies
• EssilorLuxottica
• HOYA Corp.
• Johnson & Johnson
• Danaher
• Lumenis
• NIDEK Co.
• Rayner
• Santen Pharmaceutical
• STAAR Surgical
• Topcon Corp.
• Ziemer Group

Additional Benefits:

• The market estimate (ME) sheet in Excel format
• 3 months of analyst support